SEC Form 4 · accession 0001123292-15-001126
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Hambleton
Officer — EVP & Chief Medical Officer
Period of report
Aug 20, 2015
Accepted (ET)
Aug 21, 2015 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 20, 2015 | A | 75,000 | $0.00 | A | 85,740 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock, which will vest according to the following schedule: 50% of the restricted stock vests on September 1, 2016 with the remainder vesting on March 1, 2017, provided the reporting person remains employed by the company through each such date.
- F2Reflects the acquisition of 1,108 shares on May 15, 2014 pursuant to the Five Prime Therapeutics, Inc. 2013 Employee Stock Purchase Plan (the "ESPP"), the acquisition of 891 shares on November 15, 2014 pursuant to the ESPP and the acquisition of 761 shares on May 15, 2015 pursuant to the ESPP.